No significant link for oseltamivir exposure or flu diagnosis with suicide in case-crossover analysis
FRIDAY, March 16, 2018 (HealthDay News) — Oseltamivir does not appear to be associated with suicide risk in pediatric patients, according to a study published in the March/April issue of the Annals of Family Medicine.
Rachel Harrington, from the University of Illinois at Chicago College of Pharmacy, and colleagues used a national administrative claims database and a case-crossover design to examine data from five influenza seasons (2009 to 2013) for 1- to 18-year-olds. The authors examined exposure to oseltamavir and assessed the correlation between oseltamavir use and suicide.
The researchers identified 21,407 suicide-related events during the study period, including 251 in oseltamivir-exposed children. There was no significant correlation with suicide for oseltamavir exposure (odds ratio, 0.64; 95 percent confidence interval, 0.39 to 1; P = 0.05) or for influenza diagnosis alone (odds ratio, 0.63; 95 percent confidence interval, 0.34 to 1.08; P = 0.1) in case-crossover analysis.
“Our findings suggest that oseltamivir does not increase risk of suicide in the pediatric population,” the authors write.
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
Most U.S. Adults Unsure Which Vaccines CDC Recommends During Pregnancy 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Dose-Dependent Link Seen for Clomiphene Citrate, Adverse Perinatal Outcomes 
Effect of Preparation Techniques Before Embryo Transfer Appears to Be Limited 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
